Compounded veterinary medications Recall

What does the FDA announcement say about status?

This FDA-published company announcement reports the recall and its instructions. It does not supply an FDA enforcement classification or a live recall-completion status. Follow the announcement and contact the firm for current guidance.

What is the scope of this recall record?

Use the official announcement to check the affected product identifiers and full scope.

This announcement was last checked on 2026-10-22. The company's announcement date, FDA publication date and this site's first observation are recorded separately.

• FDA company recall announcement

FDA company announcement

SWEDESBORO, N.J., (October 21, 2026) - Wedgewood Pharmacy LLC ("Wedgewood") is recalling certain compounded veterinary medications within expiry at the provider/customer level due to inconsistencies in the reliability of certain analytical testing data generated by their laboratory, potentially resulting in subpotent and/or superpotent products. The affected products were shipped between February 18, 2026 and October 6, 2026 to veterinary practices, pharmacies, and other customers nationwide in the U.S. The issue was discovered through Wedgewood’s own quality processes. A complete list of affected products (including powders, pastes, oral suspensions, injectables, ophthalmic ointments and solutions, ear solutions and suspensions, topical sprays, and gels), lot numbers, and expiration dates are available at www.wedgewood.com/recall-lookup/. The products involved are intended for companion, equine, exotic, zoo, wildlife, and aquatic animals. They are not intended for use in food-producing animals. Hazard Statement: The health risks involved with low potency can include ineffective treatment and the health risks involved with high potency can include toxicity or overdose. To date, Wedgewood has received 98 complaints, of which 7 are serious. Customers should contact their veterinarians if they have medical concerns. For customers: Wedgewood has engaged Sedgwick to support the coordination of this recall. Sedgwick is notifying affected customers via email and mail and is arranging a refund or, where possible, replacement of recalled products. Animal owners who have received affected product should stop use, retain the product, and contact Wedgewood’s recall services by phone at 866-562-5931 Monday through Friday 8am – 9pm ET and Saturday 9am to 5pm ET. For businesses: Veterinary practices, pharmacies, and other customers should immediately examine their inventory, quarantine any affected product and contact Wedgewood’s recall services by phone at 866-562-5931 Monday through Friday 8am – 9pm ET and Saturday 9am to 5pm ET. Veterinary practices or pharmacies who have further dispensed affected product should identify and notify their customers of the recall. For clinical alternatives: Wedgewood is working to help customers, veterinarians, and pet owners maintain continuity of care, including identifying clinically appropriate alternatives where available. To identify alternative treatment options, customers can contact Sedgwick by phone at 866-562-5931 Monday through Friday 8am – 9pm ET and Saturday 9am to 5pm ET. Sedgwick will refer any clinical questions to Wedgewood’s care team. This recall is being conducted with the knowledge of the U.S. Food and Drug Administration. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA at 1888-FDA-VETS or online at http://www.FDA.gov/reportanimalae.